Remove 2023 Remove Patent Remove Patent Law
article thumbnail

2023 Federal Circuit Case Summaries

Intellectual Property Law Blog

The Spring 2023 Quarterly Report provides summaries of most key patent law-related decisions from January 1, 2023 to March 31, 2023. We are excited to share Sheppard Mullin’s inaugural quarterly report on key Federal Circuit decisions. Click here to read more.

Reporting 262
article thumbnail

DHC IPD Second Annual Report 2023-24: Key Takeaways!

SpicyIP

Image from here IP Court watchers will be pleased to know that the Delhi High Court’s IP Division has published the 2023-24 edition of its Annual Report ! Praharsh had written about the first report published in April 2023. A total of 1977 cases across patents, copyrights and trademarks, were received from the IPAB in 2022.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The UPC's first decision on infringement by equivalence (Plant-e v Bioo, UPC_CFI_239/2023)

The IPKat

In Plant-e v Bioo the UPC provided its first decision addressing the doctrine of equivalents in patent infringement proceedings ( UPC_CFI_239/2023 ). Legal background: Equivalence around Europe The Unified Patent Court Agreement (UPCA) contains no specific provisions on the doctrine of equivalence.

article thumbnail

IPKat Book of the Year Awards 2023 winners announced!

The IPKat

Thank you to readers who voted for the IPKat book of the year awards 2023! Here are the nominees and winners: Best Patent Law Book The nominations, in no particular order, were: • Der patentrechtliche Schutz von Daten und seine Grenzen; Landscheidt, by Fabian Landscheidt. The Unitary Patent Package and Unified Patent Court. .

article thumbnail

Anticipation and Obviousness in Patent Law: An Analysis of Recent IPR Decisions

Intellectual Property Law Blog

16, 2023) , the case addresses the Board’s anticipation and obviousness determinations in two IPRs (IPR2020-00002 and IPR2020-00004), where the Board held the claims in the challenged patents unpatentable as anticipated by, or obvious in view of, the asserted prior art. Patent Nos. In Incept v. 6,624,245 to Wallace et al.

article thumbnail

Canadian Patent Law 2023: A Year in Review

JD Supra Law

In our annual review of developments in Canadian patent law, we considered over 60 patent decisions reported last year. This article highlights statutory changes and a selection of interesting points addressed in the reported decisions. By: Smart & Biggar

article thumbnail

A Rare Invocation for a Rare Disease?: Government Urged to Invoke Section 100, Patents Act for Rare Disease Medicine

SpicyIP

Rajya Sabha MP Haris Beeran wrote to the Minister of Health and Family Welfare on December 20, 2024, urging the Central Government to invoke Section 100 (1) of the Patents Act with respect to local production of the rare disease Spinal Muscular Atrophy (SMA) treating drug Risdiplam. 72 lakhs for children (12 bottles) and Rs 1.86